Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia.

Link to article at PubMed

Related Articles

Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia.

Thorax. 2013 May;68(5):493-5

Authors: Rodrigo C, Mckeever TM, Woodhead M, Lim WS, British Thoracic Society

Abstract
The benefits of β-lactam/macrolide combination therapy over β-lactam therapy alone for the treatment of hospitalised community-acquired pneumonia (CAP) in relation to pneumonia severity are uncertain. We studied 5240 adults hospitalised with CAP from 72 secondary care trusts across England and Wales. The overall 30-day inpatient (IP) death rate was 24.4%. Combination therapy was prescribed in 3239 (61.8%) patients. In a multivariable model, combination therapy was significantly associated with lower 30-day IP death rate in patients with moderate-severity CAP (adjusted OR 0.54, 95% CI 0.41 to 0.72) and high-severity CAP (adjusted OR 0.76, 95% CI 0.60 to 0.96) but not low-severity CAP.

PMID: 23076390 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published.